Skip to main content
SpringerLink
Log in

Is HA-1A Cost-Effective?

Schulman KA, Glick HA, Rubin MD, Eisenberg JM. Cost-effectiveness of HA-1A monoclonal antibody for Gram-negative sepsis. Economic assessment of a new therapeutic agent. Journal of the American Medical Association 266: 3466–3471. 1991

  • Current Comment
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Is HA-1A Cost-Effective?. Pharmacoeconomics 3, 84–86 (1993). https://doi.org/10.2165/00019053-199303010-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199303010-00008

Keywords

Search

Navigation